Mast Blend 200 (Mast E 150mg + Mast P 50mg)

Description

Mast Blend 200 combines 150mg/mL Masteron Enanthate with 50mg/mL Masteron Propionate in a 200mg/mL total Drostanolone formulation — the dual-ester Masteron approach for faster onset with sustained long-acting coverage. The Masteron Propionate fraction (50mg) delivers rapid plasma elevation after the first injection, producing the compound’s characteristic anti-oestrogenic, hardening, and androgenic effects from the start of the cycle. The Masteron Enanthate fraction (150mg) simultaneously builds the longer-acting Drostanolone depot that sustains through twice-weekly injection with minimal fluctuation. Masteron’s pharmacological profile makes it uniquely valuable in the final weeks of a cycle or competition preparation: its 5-alpha-reduced nature means no oestrogen conversion, its androgen receptor binding directly enhances muscle hardness and density, and its competitive aromatase inhibition reduces oestrogen at the source. The blend delivers all of this with from-day-one onset. Verified at 99%+ purity by Puralytix. Twice-weekly injection at 1mL delivers 200mg of total Drostanolone with both ester fractions active. The 150:50 enanthate-to-propionate ratio biases the blend toward the longer-acting formulation — producing sustained coverage with the early-cycle onset advantage of Propionate’s contribution. For pre-contest users who want Masteron’s full profile without managing two separate injections and vials, Mast Blend 200 consolidates everything into a single draw.